Your browser doesn't support javascript.
loading
The Calcium Channel Blocker Bepridil Demonstrates Efficacy in the Murine Model of Marburg Virus Disease.
DeWald, Lisa Evans; Dyall, Julie; Sword, Jennifer M; Torzewski, Lisa; Zhou, Huanying; Postnikova, Elena; Kollins, Erin; Alexander, Isis; Gross, Robin; Cong, Yu; Gerhardt, Dawn M; Johnson, Reed F; Olinger, Gene G; Holbrook, Michael R; Hensley, Lisa E; Jahrling, Peter B.
Afiliação
  • DeWald LE; Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland.
  • Dyall J; Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland.
  • Sword JM; Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland.
  • Torzewski L; Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland.
  • Zhou H; Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland.
  • Postnikova E; Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland.
  • Kollins E; Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland.
  • Alexander I; Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland.
  • Gross R; Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland.
  • Cong Y; Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland.
  • Gerhardt DM; Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland.
  • Johnson RF; Emerging Viral Pathogens Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland.
  • Olinger GG; Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland.
  • Holbrook MR; Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland.
  • Hensley LE; Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland.
  • Jahrling PB; Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland.
J Infect Dis ; 218(suppl_5): S588-S591, 2018 11 22.
Article em En | MEDLINE | ID: mdl-29982632
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bloqueadores dos Canais de Cálcio / Bepridil / Doença do Vírus de Marburg Limite: Animals Idioma: En Revista: J Infect Dis Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bloqueadores dos Canais de Cálcio / Bepridil / Doença do Vírus de Marburg Limite: Animals Idioma: En Revista: J Infect Dis Ano de publicação: 2018 Tipo de documento: Article